Fatty Liver Treatment in Dubai with Advanced Fibroscan® Analytics
Eliminate the anxiety surrounding your liver health. Experience absolute diagnostic precision for liver fat and fibrosis markers in under 15 minutes, completely painlessly. Managed seamlessly by Professor Dr. Hamed Zamani at elite facilities within Dubai Healthcare City — Umm Hurair 2.
Years Medical Expertise
European & US Standards
Successfully Treated Patients
Approved Fibroscan® Suite
Understanding Fatty Liver Disease
Risks and Metabolic Triggers in the UAE
Non-alcoholic Fatty Liver Disease (NAFLD/MASLD) is characterized by an abnormal accumulation of lipids within hepatocytes. Due to rapid lifestyle accelerations, metabolic factors, insulin resistance, and rising obesity curves, it directly affects over 30% of the UAE population.
Operating out of our ultra-modern facilities in Dubai Healthcare City (Umm Hurair 2), Professor Dr. Hamed Zamani orchestrates an integrated curative pathway designed to capture early-stage anomalies and reverse them completely before cellular scarring (fibrosis) sets in.
Critical Medical Note: Approximately 80% of individuals suffering from fatty liver manifest zero noticeable symptoms until the disease reaches dangerous thresholds. Proactive screening via non-invasive parameters remains the ultimate preventive shield.
Painless Evaluation via
State-of-the-Art Fibroscan®
Unlike traditional liver biopsies which are invasive, painful, and require significant recovery time, Fibroscan® technology provides an effortless, non-invasive diagnostic solution.
Using advanced transient elastography, the system measures continuous liver stiffness (indicating scarring/fibrosis grade) and Controlled Attenuation Parameter (CAP score, indicating exact fat volume) within a single 10-15 minute office session. Fasting for 3 hours prior to your session is all that is required.
- Zero needles or incisions
- Real-time quantified fat scores
- Immediate consultation & lifestyle roadmapping
The Clinical Stages of Hepatic Steatosis From initial fat retention to irreversible structural damage
Simple Steatosis (Grade 1)
Initial baseline fat build-up around individual hepatocytes. Entirely asymptomatic but serves as a crucial metabolic warning. 100% reversible through strategic dietary shifts.
NASH / Inflammatory (Grade 2)
Steatohepatitis develops as fat sparks cellular inflammation. Fibroscan analytics at this stage show rising tissue stiffness. Requires targeted clinical therapeutics.
Fibrosis & Cirrhosis (Grade 3/4)
Continuous inflammation leaves extensive collagen permanent scar sheets. Restricts regional portal circulation. Early detection eliminates the risk of progressive structural failure.